Mark Suett, MB, ChB

Teva UK Limited, Harlow, United Kingdom

  • 3Articles
  • 13.1KReads
  • 2023–2026Active
  • 13Collaborators
  • 21Citations

About

Mark Suett, MB, ChB is affiliated with Teva UK Limited, Harlow, United Kingdom. Mark Suett has authored or co-authored 3 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2023 and 2026. Their work focuses on Schizophrenia/Schizoaffective Disorders and Bipolar Disorder.

Publications

JCP
Outcomes and Practice Patterns of LAI Versus Oral Antipsychotics Among Patients With Bipolar I Disorder in the US
JCP
LAI Implementation After Schizophrenia Diagnosis
JCP
Predictors for Initiation of LAIs in Individuals With Early-Phase Schizophrenia

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.